Oppenheimer analyst Suraj Kalia downgraded Titan Medical (NASDAQ: TMDI) from Outperform to Perform.The analyst commented, "Titan reported 4Q21 revs. of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE